<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03873298</url>
  </required_header>
  <id_info>
    <org_study_id>0135-18-rmc</org_study_id>
    <nct_id>NCT03873298</nct_id>
  </id_info>
  <brief_title>Inhaled NO in IPF and COPD During 6 Minute Walk Test</brief_title>
  <official_title>The Influence of Inhaled Nitric Oxide on Oxygen Saturation of Patients With COPD and IPF During Six Minute Walk Test.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bellerophon</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our objective is to evaluate the influence of inhaled NO on the saturation and exercise
      capacity of patients with COPD and IPF. each participant will undergo two six minute walk
      tests, one with inhaled NO and the other with placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomiized, placebo controlled trail that will evaluate the influence of inhaled
      NO (INO) on the saturation and exercise capacity of patients with COPD and IPF. All patients
      will sign a consent form before enrolment. Each patient will undergo two six-minute walk
      tests. Whether the INO will be used in the first or the second trial will be determined by
      computer generated randomization with random numbers sealed in opaque envelops. For the
      placebo 6-minute test we will use placebo cartridges in the INO generator, for INO 6-minute
      test we will use NO cartridges. The treatment with INO or placebo will start 20 minutes
      before the 6-minute walk test and will end at the end of the 6-minute walk test. Between
      tests a time interval of at least 60 minutes will be kept. During the test, the patients'
      pulse and saturation level will be monitored with a pulse oximetry. The data will be recorded
      continuously from baseline to 5 minutes after the test is over. The distance the patient
      walked will also be recorded. Patients that require supplemental oxygen will perform the
      tests with oxygen supplementation.

      Dosing The NO dosing will be fixed. The first 10 patients will be treated with INO at a dose
      of 45 parts per million (ppm) per kilogram (kg). from patient 10 to 20 a dose of 75 ppm per
      kg will be given and from patient 20-100 a dose of 115 ppm per kg will be given.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 4, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>RCT, placebo controlled</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The participants don't know if the cartridge used in the INO device is placebo or NO</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Saturation level during the test</measure>
    <time_frame>26 minutes</time_frame>
    <description>AUC of the saturation value during six minute walk test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COPD</condition>
  <condition>IPF</condition>
  <condition>Inhaled Nitric Oxide</condition>
  <condition>Six Minute Walk Test</condition>
  <condition>Oxygen Saturation</condition>
  <arm_group>
    <arm_group_label>COPD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant will undergo two six minute walk tests and the results will be compared within each subject.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IPF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant will undergo two six minute walk tests and the results will be compared within each subject.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled nitric oxide</intervention_name>
    <description>Inhaled nitric oxide delivered through a pulsatile nitric oxide drug delivery system</description>
    <arm_group_label>COPD</arm_group_label>
    <arm_group_label>IPF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with COPD with disease severity of GOLD stage 3-4

          2. Patients with IPF with a Forced vital capacity under 80% and a diffusion capacity
             under 60%

          3. Ambulatory patients that can perform a 6-minute walk test

        Exclusion Criteria:

          1. Patients with moderate to severe heart failure - EF &lt; 40%

          2. Patients with severe PVD or scleroderma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mordechai Kramer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rabin Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barak Pertzov, MD</last_name>
    <phone>972548080196</phone>
    <email>pertzovb@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mordechai R Kramer, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mordechai R Kramer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2019</study_first_posted>
  <last_update_submitted>December 24, 2019</last_update_submitted>
  <last_update_submitted_qc>December 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>Mordechai Kremer</investigator_full_name>
    <investigator_title>Head of the pulmonary division</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

